A federal appeals court has upheld parts of the Food and Drug Administration’s decades-old approval of the abortion pill, mifepristone, in a divided ruling that also reversed the FDA’s subsequent rules expanding access.
Aug. 16 A federal appeals court has upheld parts of the Food and Drug Administration’s decades-old approval of the abortion pill mifepristone in a divided ruling that also found the FDA ignored safety concerns as it expanded access to the drug in 2016.
